STAT3 and pulmonary fibrosis: Similarly, studies carried out by Li Z et al. (2022) indicated that DHM has the capacity to adjust the STAT3/p-STAT3/GLUT1 signaling pathway, mitigating pulmonary fibrosis induced in a mouse model by bleomycin (BLM).